Research
Hormonal
Early and intensive glycemic control, particularly within the first two years of diagnosis, is associated with a lower risk of long-term diabetes-related complications and can lead to diabetes remission in some patients.
If you are newly diagnosed with type 2 diabetes, starting treatment early is crucial. It can help prevent long-term complications and even lead to remission in some cases. Don't delay seeking medical advice or starting prescribed therapies.
GoodSupportsHIGH confidence
Early and intensive treatment of type 2 diabetes (T2D) has been associated with lower risk of diabetes-related complications.
Why this rating
Based on long-term studies like UKPDS and ORIGIN.
Source
Glycaemic Control and Weight Reduction: A Narrative Review of New Therapies for Type 2 Diabetes
Luis Alberto Vázquez et al. · Diabetes Therapy · 2023
DOI 10.1007/s13300-023-01467-5
narrative_reviewCited 6×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →